Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA
Go back to Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA| Amgen Inc (NASDAQ: AMGN) | Delayed: 433.73 -8.63 (1.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $442.36 | 52 Week High | $176.85 | |||
| Open | $435.78 | 52 Week Low | $133.64 | |||
| Day High | $441.34 | P/E | 65.32 | |||
| Day Low | $431.07 | EPS | $6.64 | |||
| Volume | 2,914,113 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 5,094,210 | |||||
